Drugs / NaCl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05993078 | Sep 2023 → Dec 2024 | brain infarction | Tianjin Medical University General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05993078 ↗ |
| Route | Intravenous | “NS 2000ml intravenous infusion” NCT05993078 ↗ |